Ibopamine and survival in severe congestive heart failure: PRIME II.
Girbes
A R
AR
Zijlstra
J G
JG
D000638:Amiodarone / Q000009:adverse effects / Q000627:therapeutic use; D000889:Anti-Arrhythmia Agents / Q000009:adverse effects / Q000627:therapeutic use; D019540:Area Under Curve; D002316:Cardiotonic Agents / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use*; D002423:Cause of Death; D003846:Deoxyepinephrine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000097:blood / Q000627:therapeutic use; D018491:Dopamine Agonists / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use; D006333:Heart Failure / Q000188:drug therapy*; D006801:Humans; D015996:Survival Rate
D000889:Anti-Arrhythmia Agents; D002316:Cardiotonic Agents; D018491:Dopamine Agonists; C023487:ibopamine; D000638:Amiodarone; D003846:Deoxyepinephrine